ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.182,10
0,46%
S&P 500
5.220,84
-0,04%
US Dollar vs BRL
5,1495
0,06%
Bitcoin
62.731,20
2,09%
Brent Oil
83,225
1,02%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Transkaryotic Therapies (MM) (TKTX)

  7. Transkaryotic Therapies (MM) (TKTX) Notícias

TKTX

Transkaryotic Therapies (TKTX)

Transkaryotic Therapies (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TKTX
DataHoraFonteTítuloCódigoCompanhia
26/02/202018:05GlobeNewswire Inc.CRISPR Therapeutics Proposes Changes to the Board of DirectorsNASDAQ:TKTXTranskaryotic Therapies (MM)
27/07/200512:36PR Newswire (US)TKT Stockholders Approve Acquisition by ShireNASDAQ:TKTXTranskaryotic Therapies (MM)
14/07/200519:22PR Newswire (US)TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire TransactionNASDAQ:TKTXTranskaryotic Therapies (MM)
12/07/200510:01PR Newswire (US)TKT Issues Open Letter to StockholdersNASDAQ:TKTXTranskaryotic Therapies (MM)
27/06/200515:14PR Newswire (US)TKT to Hold Special Meeting of Stockholders on July 27, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
20/06/200510:01PR Newswire (US)TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
13/06/200510:41PR Newswire (US)TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy StatementNASDAQ:TKTXTranskaryotic Therapies (MM)
05/05/200510:00PR Newswire (US)TKT Announces First Quarter 2005 ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
27/04/200520:23PR Newswire (US)TKT Assessing Impact of Fire at Manufacturing FacilityNASDAQ:TKTXTranskaryotic Therapies (MM)
27/04/200518:30PR Newswire (US)TKT to Report First Quarter 2005 Financial Results on May 5, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
21/04/200511:50PR Newswire (US)TKT Announces Agreement to be Acquired by Shire for $1.6 BillionNASDAQ:TKTXTranskaryotic Therapies (MM)
20/04/200511:43PR Newswire (US)TKT Achieves GA-GCB Clinical MilestoneNASDAQ:TKTXTranskaryotic Therapies (MM)
29/03/200517:23PR Newswire (US)TKT Announces Appointment of Eric Pauwels as Senior Vice President, Global Commercial OperationsNASDAQ:TKTXTranskaryotic Therapies (MM)
28/03/200519:04PR Newswire (US)New Website Offers Comprehensive Information on Hunter SyndromeNASDAQ:TKTXTranskaryotic Therapies (MM)
24/03/200511:30PR Newswire (US)TKT to Present at Two Upcoming Healthcare ConferencesNASDAQ:TKTXTranskaryotic Therapies (MM)
17/03/200510:01PR Newswire (US)Notice to All Deutsche Bank Securities Inc. Clients From the Securities Arbitration Law Firm of Klayman & Toskes, P.A.NASDAQ:TKTXTranskaryotic Therapies (MM)
09/03/200516:21PR Newswire (US)TKT to Present at SG Cowen Securities' 25th Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
23/02/200510:00PR Newswire (US)Strong Year of Execution Produces Solid 2004 Financial PerformanceNASDAQ:TKTXTranskaryotic Therapies (MM)
15/02/200512:31PR Newswire (US)Tamara L. Joseph Named General Counsel of TKTNASDAQ:TKTXTranskaryotic Therapies (MM)
10/02/200512:17PR Newswire (US)TKT to Report Fourth Quarter and Year-End 2004 Financial Results on February 23, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
04/02/200512:15PR Newswire (US)TKT Appoints Theresa Heggie as General Manager, EuropeNASDAQ:TKTXTranskaryotic Therapies (MM)
24/01/200518:59PR Newswire (US)Genzyme Sues to Halt TKT Gaucher TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
11/01/200519:01PR Newswire (US)TKT Provides Update on Product Pipeline at JPMorgan Healthcare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
04/01/200513:02PR Newswire (US)TKT to Present at JPMorgan's Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
09/12/200414:23PR Newswire (US)TKT to Present at Wachovia Biotechnology ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
12/11/200412:15PR Newswire (US)TKT Announces Executive PromotionsNASDAQ:TKTXTranskaryotic Therapies (MM)
09/11/200411:35PR Newswire (US)TKT to Present At SG Cowen's Fifth Annual Global Health Care ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
09/11/200411:30PR Newswire (US)TKT Reports Third Quarter 2004 Financial ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
29/10/200417:58PR Newswire (US)TKT To Report Third Quarter Financial Results On November 9, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
28/10/200419:01PR Newswire (US)TKT's Research Findings on Intrathecal Delivery of I2S Presented at ASHGNASDAQ:TKTXTranskaryotic Therapies (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:TKTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
VVEO3
CM Hospitalar ON
BOV
COGN3
COGNA ON
BOV
HAGA3
HAGA ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
AZEV4
AZEVEDO PN
BOV
AMAR3
LOJAS MARISA ON
BOV
LUPA3
LUPATECH ON
BOV
ETER3
ETERNIT ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
TECN3
TECHNOS ON
BOV
CASH3
Meliuz S.A ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados